People with ulcerative colitis are susceptible to an infection from a bacterium called Clostridioides difficile, or C. diff. Here’s what to do if you think you have it.

Study finds traditional fecal transplant outperforms new pill in severe C. diff. cases by Kendall Daniels Rovinsky, University of North Carolina at Chapel Hill School of Medicine ...

The bacterium Clostridium difficile — otherwise known as C. diff — spreads within intensive care units more than three times as much as previously thought, according to a study published on ...

The pathogen C. diff—the most common cause of health care-associated infectious diarrhea—can use a compound that kills the human gut's resident microbes to survive and grow, giving it a ...

The pathogen C. diff -- the most common cause of health care-associated infectious diarrhea -- can use a compound that kills the human gut's resident microbes to survive and grow, giving it a ...

The pathogen C. diff - the most common cause of health care-associated infectious diarrhea - can use a compound that kills the human gut's resident microbes to survive and grow, giving it a ...

Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease duration, previous use of corticosteroids, and prior hospitalisation.

Researchers found that removing Clostridioides difficile from gastrointestinal pathogen panels reduced unnecessary treatment without causing delays in diagnosis.

The portion of our nervous systems responsible for the "fight or flight" response can shape the severity of potentially deadly C. difficile infections, new research from the University of Virginia ...

The vaccine could become a tool to target different strains of C. diff and prevent the pesky bacteria from trapping patients in a cycle of disease.

An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.